T cells in PDAC tumors are limited and express TFs with suppressive phenotypic properties. A, Representative images of mIHC staining in primary and metastatic tumors. Antibody panel detecting CD8 (red), CD4 (yellow), CK19 (white), and dual CD4+CD8+ cells (orange), with representative cells shown. Scale bar, top, 1,000 μm; bottom, 100 μm. B, Representative single-channel images of CD4+, CD8+, and CD4+CD8+ cell subsets (DAPI, CD4, CD8, and CK19). C and D, Stacked bar graphs show the distribution of CK19+, CD4+, CD8+, CD4+CD8+, and DAPI+CK19−CD4−CD8− (other) cells detected by mIHC in each patient sample as percent of total cells (C) and percent of total phenotyped cells (D). Samples arranged from high to low based on other and CK19+ cells, respectively. E, Bar graphs show the mean ± SD of each T-cell subset (P values indicated). F, Bar graphs show the mean ± SD of TF (T-bet, FoxP3, and RORγt)-positive CD4+ T-cell populations, represented as a percentage of total CD4+ T cells (P values of significant results indicated). G, Representative images of CD4+ T-cell subsets by single-channel DAPI, CD4, CD8, CK19, T-bet, FoxP3, and RORγt. Sample size: primary, n = 24; metastatic, n = 21. E, Statistical analysis was performed using two-way ANOVA; F, statistical analysis was performed using Mann–Whitney tests.